ENTRY       D00780                      Drug
NAME        Bromocriptine mesylate (USP);
            Bromocriptine mesilate (JP18);
            Parlodel (TN)
PRODUCT     CYCLOSET (Santarus)
            PARLODEL (Validus Pharmaceuticals LLC)
  GENERIC   BROMOCRIPTINE MESYLATE (American Health Packaging)
            BROMOCRIPTINE MESYLATE (Mylan Pharmaceuticals)
            BROMOCRIPTINE MESYLATE (Padagis US LLC)
            BROMOCRIPTINE MESYLATE (Sandoz)
            BROMOCRIPTINE MESYLATE (Zydus Lifesciences Limited)
            BROMOCRIPTINE MESYLATE (Zydus Pharmaceuticals USA)
FORMULA     C32H40BrN5O5. CH4SO3
EXACT_MASS  749.2094
MOL_WEIGHT  750.7002
CLASS       Neuropsychiatric agent
             DG01472  Dopamine agonist
              DG01468  Dopamine D2-receptor agonist
             DG01964  Ergot alkaloid
             DG01967  Antiparkinson agent
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
            Metabolizing enzyme inhibitor
             DG02852  CYP3A/CYP3A4 inhibitor
              DG01522  CYP3A4 inhibitor
REMARK      Therapeutic category: 1169
            ATC code: G02CB01 N04BC01
            Chemical structure group: DG00452
            Product (DG00452): D00780<JP/US>
EFFICACY    Antiparkinsonian, Dopamine D2 receptor agonist, Prolactin inhibitor
  DISEASE   Hyperprolactinemia [DS:H01388]
            Acromegaly [DS:H01483]
            Parkinson disease [DS:H00057]
COMMENT     Ergot alkaloid derivative
TARGET      DRD2 [HSA:1813] [KO:K04145]
            PRL [HSA:5617] [KO:K05439]
  PATHWAY   hsa04080(1813+5617)  Neuroactive ligand-receptor interaction
            hsa04728(1813)  Dopaminergic synapse
            hsa04917(5617)  Prolactin signaling pathway
            hsa05012(1813)  Parkinson disease
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION CYP inhibition: CYP3A4 [HSA:1576]
STR_MAP     map07057  Antiparkinsonian agents
            map07213  Dopamine receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G02 OTHER GYNECOLOGICALS
               G02C OTHER GYNECOLOGICALS
                G02CB Prolactine inhibitors
                 G02CB01 Bromocriptine
                  D00780  Bromocriptine mesylate (USP) &lt;JP/US&gt;
             N NERVOUS SYSTEM
              N04 ANTI-PARKINSON DRUGS
               N04B DOPAMINERGIC AGENTS
                N04BC Dopamine agonists
                 N04BC01 Bromocriptine
                  D00780  Bromocriptine mesylate (USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antiparkinson Agents
              Dopamine Agonists
               Bromocriptine
                D00780  Bromocriptine mesylate (USP)
             Blood Glucose Regulators
              Antidiabetic Agents
               Glucose Control Agents, Other
                Bromocriptine
                 D00780  Bromocriptine mesylate (USP)
             Hormonal Agents, Suppressant (Pituitary)
              Bromocriptine
               D00780  Bromocriptine mesylate (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               116  Antiparkinsonian agents
                1169  Others
                 D00780  Bromocriptine mesylate (USP); Bromocriptine mesilate (JP18)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01472  Dopamine agonist
               DG01468  Dopamine D2-receptor agonist
                DG00452  Bromocriptine
                 D00780  Bromocriptine mesylate
              DG01964  Ergot alkaloid
               DG00452  Bromocriptine
                D00780  Bromocriptine mesylate
              DG01967  Antiparkinson agent
               DG00452  Bromocriptine
                D00780  Bromocriptine mesylate
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00452  Bromocriptine
                 D00780  Bromocriptine mesylate
             Metabolizing enzyme inhibitor
              DG02852  CYP3A/CYP3A4 inhibitor
               DG01522  CYP3A4 inhibitor
                DG00452  Bromocriptine
                 D00780  Bromocriptine mesylate
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG01967  Antiparkinson agent
               D00780  Bromocriptine mesylate
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Dopamine
                DRD2
                 D00780  Bromocriptine mesylate (USP) &lt;JP/US&gt;
             Cytokines and receptors
              Cytokines
               CSF and other factors
                PRL
                 D00780  Bromocriptine mesylate (USP) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00780  Bromocriptine mesilate
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00780
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01472  Dopamine agonist
               DG01468  Dopamine D2-receptor agonist
                DG00452  Bromocriptine
              DG01964  Ergot alkaloid
               DG00452  Bromocriptine
              DG01967  Antiparkinson agent
               DG00452  Bromocriptine
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00452  Bromocriptine
             Metabolizing enzyme inhibitor
              DG02852  CYP3A/CYP3A4 inhibitor
               DG01522  CYP3A4 inhibitor
                DG00452  Bromocriptine
DBLINKS     CAS: 22260-51-1
            PubChem: 7847845
            ChEBI: 3182
            LigandBox: D00780
            NIKKAJI: J289.977I
ATOM        48
            1   N1y N    24.4872  -13.9365
            2   C1z C    24.5044  -12.6229
            3   C5x C    22.2157  -13.9306
            4   C1y C    25.6229  -14.6074
            5   C1y C    25.6516  -11.9690
            6   O2x O    23.3630  -11.9575
            7   O1a O    24.4872  -10.9506
            8   C1z C    22.2216  -12.6057
            9   O5x O    21.8660  -15.1983
            10  C5x C    26.8341  -13.9649
            11  C1b C    25.6056  -16.1956
            12  N1y N    26.7986  -12.6287
            13  C1x C    25.6401  -10.6556
            14  N1b N    21.0803  -11.9518
            15  C1c C    22.2157  -10.8767
            16  O5x O    27.9057  -14.6188
            17  C1x C    27.9229  -11.9518
            18  C1x C    27.9114  -10.6382
            19  C5a C    19.9444  -12.6172
            20  C1a C    23.1451   -9.7359
            21  C1a C    21.5504   -9.7298
            22  C1y C    19.9329  -13.9306
            23  O5a O    18.7975  -11.9403
            24  C2x C    18.7916  -14.5787
            25  C1x C    21.0687  -14.5959
            26  C2y C    18.7800  -15.8922
            27  N1y N    21.0572  -15.9095
            28  C8y C    17.6331  -16.5518
            29  C1y C    19.9100  -16.5576
            30  C8y C    17.6331  -17.8540
            31  C8x C    16.4972  -15.8865
            32  C1x C    19.9100  -17.8769
            33  C8y C    18.7800  -18.5135
            34  C8y C    16.4917  -18.5135
            35  C8x C    15.3558  -16.5518
            36  C8y C    18.7745  -19.8269
            37  N4x N    16.4917  -19.8269
            38  C8x C    15.3558  -17.8710
            39  X   Br   19.9043  -20.4865
            40  C1c C    26.8144  -16.9003
            41  C1a C    28.0393  -16.2001
            42  C1a C    26.8085  -18.2700
            43  C1a C    22.2640  -16.6209
            44  S4a S    30.0087  -19.4145
            45  C1a C    28.6380  -19.4088
            46  O1d O    31.3853  -19.4145
            47  O1d O    30.0031  -18.0438
            48  O1d O    30.0031  -20.7911
BOND        53
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 1
            6     2   7 1 #Down
            7     3   8 1
            8     3   9 2
            9     4  10 1
            10    4  11 1 #Down
            11    5  12 1
            12    5  13 1
            13    8  14 1
            14    8  15 1 #Up
            15   10  16 2
            16   12  17 1
            17   13  18 1
            18   14  19 1
            19   15  20 1
            20   15  21 1
            21   22  19 1 #Up
            22   19  23 2
            23   22  24 1
            24   22  25 1
            25   24  26 2
            26   25  27 1
            27   26  28 1
            28   26  29 1
            29   28  30 1
            30   28  31 2
            31   29  32 1
            32   30  33 1
            33   30  34 2
            34   31  35 1
            35   33  36 2
            36   34  37 1
            37   34  38 1
            38   36  39 1
            39    6   8 1
            40   10  12 1
            41   17  18 1
            42   27  29 1
            43   32  33 1
            44   35  38 2
            45   36  37 1
            46   11  40 1
            47   40  41 1
            48   40  42 1
            49   27  43 1
            50   44  45 1
            51   44  46 1
            52   44  47 2
            53   44  48 2
///
